Corcept Therapeutics | CORT - Betriebsaufwand

Aktienkurs
46.06
Täglich Wechseln
0.98 2.17%
Monatlich
13.81%
Jährlich
-35.77%
Q2 Prognose
45.07




Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 129.98M 16.05M 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 83.21M 14.06M 2025-12
J&J USD 17.44B 1.53B 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Merck USD 10.16B 558M 2025-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novartis USD 9.8B 61M 2025-12
Novartis USD 9.8B 23M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 193.68M 27.32M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
TG Therapeutics USD 142.08M 9.74M 2025-12